Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL726736 | 0.85 | TDP1 (0.41) | TDP1CHRNB4CHRNA3TSHR | |
| SCHEMBL4243856 | 0.77 | CHRNB4 (0.49) | TDP1CHRNB4CHRNA3TSHR | |
| SCHEMBL28130310 | 0.76 | SLC6A2 (0.39) | TDP1TSHR | |
| SCHEMBL28797072 | 0.74 | CHRNB4 (0.42) | CA4CHRNB4CHRNA3 | |
| SCHEMBL9589101 | 0.74 | MEN1 (0.37) | TDP1 | |
| SCHEMBL6098824 | 0.73 | TDP1 (0.41) | TDP1CHRNB4CHRNA3TSHR | |
| SCHEMBL6098832 | 0.73 | TDP1 (0.41) | TDP1CHRNB4CHRNA3TSHR | |
| SCHEMBL10829460 | 0.73 | TDP1 (0.41) | TDP1CHRNB4CHRNA3TSHR | |
| SCHEMBL6021886 | 0.73 | TDP1 (0.42) | TDP1CHRNB4CHRNA3TSHR | |
| Acrylic Acid SCHEMBL4400635 | 0.73 | THRB (0.35) | TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5254595-A | Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them | ELF SANOFI (FR) | 1993-10-19 | — | — | US | disclosed |
| EP-0005610-A2 | 1-(Heterocyclylalkyl)-1,3-dihydro-2H-benzimidazol-2-ones, their preparation, their pharmaceutical compositions and their use as beta-adrenergic receptor blockers | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-11-28 | — | — | EP | disclosed |